Acurx Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acurx pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acurx Pharma Today - Breaking & Trending Today

Acurx Pharma Discontinues Phase 2b Trial For Ibezapolstat To Treat C. Difficile Infection

Biopharmaceutical company Acurx Pharmaceuticals, Inc. (ACXP) announced Monday that the Company has discontinued the Phase 2b clinical trial of its lead antibiotic candidate, ibezapolstat, for the treatment of patients with Clostridioides difficile infection (CDI) due to success. ....

Data Monitoring Committee , Acurx Pharmaceuticals Inc , Acurx Pharmaceuticals , Independent Data Monitoring Committee , Fast Track Designated , Acurx Pharma , Clostridioides Difficile Infection ,